The power of combinative capabilities: facilitating the outcome of frequent innovation in pharmaceutical R&D projects
2011 (English)In: Project Management Journal, ISSN 8756-9728, E-ISSN 1938-9507, Vol. 42, no 2, 63-80 p.Article in journal (Refereed) Published
The purpose of this article is to investigate how organizations organize the early phases of research and development (R&D) projects in the pharmaceutical industry to achieve frequent innovation. The investigation was designed as a qualitative multiple case study. The analysis identified a standardized projectification of the preproject phases, leading to certain conflicts, such as a severe tension between dynamic, project, and multiproject capabilities, which hamper frequent innovation. Optimizing combinative capabilities to balance the capabilities triumvirate can provide powerful leverage and boost frequent innovation.
Place, publisher, year, edition, pages
2011. Vol. 42, no 2, 63-80 p.
combinative capabilities; dynamic capabilities; project capabilities; multiproject capabilities; pharmaceutical innovation
Research subject Business Studies
IdentifiersURN: urn:nbn:se:umu:diva-40253DOI: 10.1002/pmj.20221OAI: oai:DiVA.org:umu-40253DiVA: diva2:398834